Comparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson's Disease Psychosis.

Golnoosh Alipour-HarisMelissa J ArmstrongMichael OkunJoshua D Brown

Published in: Movement disorders clinical practice (2023)

Risk of hospitalization was lower in pimavanserin users compared with quetiapine, and no difference in mortality was observed between pimavanserin and quetiapine. An active comparator analyses with treatment alternatives provided the most clinically relevant information for patients and physicians.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
primary care
peritoneal dialysis
cardiovascular events
cardiovascular disease
patient reported outcomes
health information
social media
smoking cessation
affordable care act